The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2026

Filed:

Jun. 17, 2019
Applicants:

Arizona Board of Regents on Behalf of the University of Arizona, Tucson, AZ (US);

The Research Foundation for the State University of New York, Albany, NY (US);

Inventors:

Marvin J. Slepian, Tucson, AZ (US);

Yana Roka-Moiia, Tucson, AZ (US);

Danny Bluestein, Stony Brook, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 5/078 (2010.01); A61K 35/19 (2015.01); C12N 13/00 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0644 (2013.01); A61K 35/19 (2013.01); C12N 13/00 (2013.01); G01N 33/68 (2013.01);
Abstract

Biochemical markers that can be measured to determine the level of mechanical activation of a population of platelets are provided, and their use to prepare molecular signatures thereof are provided. The markers include phosphatidylserine, thrombin, integrin GPIIb/IIIa activation, glycoprotein GP Ib, P-selectin; platelet size; microparticle generation, or lipidomic profile of the membrane. The disclosed markers, measurement thereof, and signatures composed therefrom can be used in a variety of methods of patient selection, treatment monitoring, treatment selection, including both devices and active agents, and methods of treating subjects in need thereof, particularly humans. Examples of such methods include, but are not limited to, reducing shear-activated platelets; selecting a blood-contacting medical device; selecting between two or more medical devices; identifying a subject at a risk of developing a thrombogenic event; monitoring the prophylactic treatment of a subject; selecting a mechanoceutical agent; and delivering an agent to a subject.


Find Patent Forward Citations

Loading…